SE7806495L - Kvevehaltiga heterocykliska foreningar - Google Patents

Kvevehaltiga heterocykliska foreningar

Info

Publication number
SE7806495L
SE7806495L SE7806495A SE7806495A SE7806495L SE 7806495 L SE7806495 L SE 7806495L SE 7806495 A SE7806495 A SE 7806495A SE 7806495 A SE7806495 A SE 7806495A SE 7806495 L SE7806495 L SE 7806495L
Authority
SE
Sweden
Prior art keywords
associations
nitrogen heterocyclic
heterocyclic
nitrogen
heterocyclic associations
Prior art date
Application number
SE7806495A
Other languages
English (en)
Other versions
SE428298B (sv
Inventor
K Kubo
N Ito
I Souzu
Y Isomura
H Homma
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Priority to SE7806495A priority Critical patent/SE428298B/sv
Publication of SE7806495L publication Critical patent/SE7806495L/sv
Publication of SE428298B publication Critical patent/SE428298B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7806495A 1978-06-02 1978-06-02 Kondenserade isokinolinderivat SE428298B (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE7806495A SE428298B (sv) 1978-06-02 1978-06-02 Kondenserade isokinolinderivat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7806495A SE428298B (sv) 1978-06-02 1978-06-02 Kondenserade isokinolinderivat

Publications (2)

Publication Number Publication Date
SE7806495L true SE7806495L (sv) 1979-12-03
SE428298B SE428298B (sv) 1983-06-20

Family

ID=20335109

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7806495A SE428298B (sv) 1978-06-02 1978-06-02 Kondenserade isokinolinderivat

Country Status (1)

Country Link
SE (1) SE428298B (sv)

Also Published As

Publication number Publication date
SE428298B (sv) 1983-06-20

Similar Documents

Publication Publication Date Title
SE7805217L (sv) Tiaazaforeningar
SE7805136L (sv) Polyenforeningar
SE7802022L (sv) Kinazolinforeningar
SE437827B (sv) Herbicidiskt aktiva foreningar
SE7907493L (sv) Anilinokinazolinderivat
SE7900380L (sv) Anisamidderivat
SE7704197L (sv) Pyridinforeningar
IT1112959B (it) Composti eterociclici
SE7706428L (sv) Kveve-heterocykliska foreningar
SE7700577L (sv) Oxiegenerade n-aryldiazacykliska foreningar
FI790281A (fi) Prostaglandin-derivat
BR7906974A (pt) Transistor
SE7801697L (sv) 1-oxadetiacefamforeningar
SE7805185L (sv) Hypolipemiska foreningar
DK361979A (da) Heterocykliske trichlormethylderivater
SE7705792L (sv) Polyamidaminforeningar
DK201279A (da) Heterocycliske forbindelser
SE7807554L (sv) Organiska foreningar
SE7703736L (sv) Organiska foreningar
SE7805578L (sv) 6-amino-penamforeningar
DK143979A (da) Chromanonderivater
BE876670R (fr) Composes heterocycliques azotes
SE8001100L (sv) Beta-laktamforeningar
SE7806852L (sv) Organiska foreningar
DK149809C (da) 1-alkylsubstituerede pyrazolderivater